Literature DB >> 25579368

Bilateral optic neuritis following Mycoplasma pneumoniae infection.

Gauri Bhushan1, Neeraj Nischal, Prateeksha Sharma, Usha Kaul Raina.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25579368      PMCID: PMC4313507          DOI: 10.4103/0301-4738.149156

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


× No keyword cloud information.
Dear Editor, We read with interest, the article on bilateral optic neuritis following Mycoplasma pneumoniae infection by Chiang and Huang.[1] Management of the case by authors was solely based on the hypothesis that optic neuritis developed secondary to an immune reaction. After going through the literature, we would like to highlight few important facts regarding the role of M. pneumoniae in cases with neurological damage. Extrapulmonary manifestations of M. pneumoniae infection especially nervous system involvement have been widely reported in the literature. Neurological injury falls into two patterns: Direct invasion by organism and secondary to an immune response. Cases when neurological involvement has been attributed to an immune complex mediated reaction, the duration of prodromal respiratory symptoms has usually been >7 days.[2] An auto-immune response causes neurological damage secondary to cytokine production, autoimmunity, and vascular occlusion. In a large case series published by Bitnun et al. the authors claim that in patients with neurological involvement they could detect M. pneumoniae antigen by polymerase chain reaction in cerebrospinal fluid/throat of patients who had at least 5–7 days of respiratory prodromal symptoms.[3] They proposed that respiratory infection can have a cytotoxic effect on respiratory epithelium, and this can facilitate blood stream invasion by M. pneumoniae. In the current case, coexistence of respiratory symptoms and visual symptoms along with raised Mycoplasma immunoglobulin (Ig) M titres (+, >75 BU/mL) raises the possibility of acute M. pneumoniae infection for the treatment of which intravenous Ig should be administered under a 2 week macrolide cover.[4] Although the response to Ig suggests an immune mechanism is involved along with acute infection, administration of high dose steroids can cause transient leucopenia which can suppress micro-organism. Holistic approach in such a case requires management of systemic status along with visual complaints. A chest X-ray at the time of presentation and a repeat serology to look for change in IgM and IgG levels would have supplemented the management. We agree with authors that in cases of optic neuritis in children with respiratory symptoms M. pneumoniae should not be overlooked as a probable cause and should be investigated for.
  4 in total

1.  Two distinct patterns of central nervous system complications due to Mycoplasma pneumoniae infection.

Authors:  M Narita; S Yamada
Journal:  Clin Infect Dis       Date:  2001-09-15       Impact factor: 9.079

2.  Acute childhood encephalitis and Mycoplasma pneumoniae.

Authors:  A Bitnun; E L Ford-Jones; M Petric; D MacGregor; H Heurter; S Nelson; G Johnson; S Richardson
Journal:  Clin Infect Dis       Date:  2001-05-21       Impact factor: 9.079

3.  Coexistence of myositis, transverse myelitis, and Guillain Barré syndrome following Mycoplasma pneumoniae infection in an adolescent.

Authors:  Yasemin Topcu; Erhan Bayram; Pakize Karaoglu; Uluc Yis; Handan Guleryuz; Semra Hiz Kurul
Journal:  J Pediatr Neurosci       Date:  2013-01

Review 4.  Bilateral monosymptomatic optic neuritis following Mycoplasma pneumoniae infection: a case report and literature review.

Authors:  Wei-Yu Chiang; Hsiu-Mei Huang
Journal:  Indian J Ophthalmol       Date:  2014-06       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.